During this panel discussion, healthcare system experts will explore the JCA process and efforts to ensure timely access to innovative healthcare products within this new framework. The discussion will consider the challenges and opportunities presented by the JCA and the potential next steps to best prepare Pharma & Biotech companies to manage the new process.
